Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study

Table 2

Comparison of ssDNA levels between different liver diseases and healthy individuals.

Subjects	No.	ssDNA (ng/μL), median (IQR)
Healthy individuals	45	9.36 (8.01-10.90)
Cirrhosis	21	9.64 (8.93-11.68)	0.15^a
Chronic hepatitis	20	9.76 (8.52-11.28)	0.39^a
HCC	102	23.20 (16.86-44.40)	<0.001^b

IQR: interquartile range. ^aComparison with healthy individuals was analyzed using the Mann–Whitney test; ^bcomparison among the multiple groups was analyzed using the Kruskal-Wallis test.